Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma

Annals of Oncology

Volumn 23, Issue 10, 2012, Pages 2642-2649

  Van der Gaag, N A ^a   Kloek, J J ^a   De Bakker, J K ^a   Musters, B ^a   Geskus, R B ^a   Busch, O R C ^a   Bosma, A ^a   Gouma, D J ^a   Van Gulik, T M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cancer specific survival; Extrahepatic cholangiocarcinoma; Prognostic model; Tumor location

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CHOLECYSTECTOMY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MINIMAL RESIDUAL DISEASE; NOMOGRAM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84867126711     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds077     Document Type: Article

References (33)

1. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75: 171-190.
2. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005; 128: 1655-1667.
3. Dinant S, Gerhards MF, Rauws EA et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 2006; 13: 872-880.
4. DeOliveira ML, Cunningham SC, Cameron JL et al. Cholangiocarcinoma: thirtyone-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755-762.
5. Seyama Y, Kubota K, Sano K et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238: 73-83.
6. Neuhaus P, Jonas S, Settmacher U et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg 2003; 388: 194-200.
7. Kawasaki S, Imamura H, Kobayashi A et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238: 84-92.
8. Paik KY, Choi DW, Chung JC et al. Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg 2008; 12: 1268-1274.
9. Hasegawa S, Ikai I, Fujii H et al. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg 2007; 31: 1256-1263.
10. Alden ME, Waterman FM, Topham AK et al. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct. Radiology 1995; 197: 511-516.
11. Argani P, Shaukat A, Kaushal M et al. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer 2001; 91: 1332-1341.
12. Heron DE, Stein DE, Eschelman DJ et al. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 2003; 26: 422-428.
13. Sakamoto Y, Kosuge T, Shimada K et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 2005; 137: 396-402.
14. Allen PJ, Reiner AS, Gonen M et al. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB (Oxford) 2008; 10: 341-346.
15. Reding R, Buard JL, Lebeau G et al. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg 1991; 213: 236-241.
16. Gouma DJ, Nieveen van Dijkum EJ, Obertop H. The standard diagnostic work-up and surgical treatment of pancreatic head tumours. Eur J Surg Oncol 1999; 25: 113-123.
17. Nieveen van Dijkum EJ, Romijn MG, Terwee CB et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 2003; 237: 66-73.
18. Tilleman EH, de Castro SM, Busch OR et al. Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. J Gastrointest Surg 2002; 6: 426-430.
19. ten Hoopen-Neumann H, Gerhards MF, van Gulik TM et al. Occurrence of implantation metastases after resection of Klatskin tumors. Dig Surg 1999; 16: 209-213.
20. Pedrazzoli S, Beger HG, Obertop H et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 1999; 16: 337-345.
21. Kayahara M, Nagakawa T, Ohta T et al. Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery? Cancer 1999; 85: 583-590.
22. van Geenen RC, Ten Kate FJ, de Wit LT et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 2001; 129: 158-163.
23. Allema JH, Reinders ME, van Gulik TM et al. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg 1994; 81: 1642-1646.
24. van Gulik TM, Kloek JJ, Ruys AT et al. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol 2011; 37: 65-71.
25. van Gulik TM, Gouma DJ. Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol 2007; 14: 1969-1971.
26. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual. Berliln, Germany 2002 Springer.
27. Sobin LH, Wittekind Ch. (eds), UICC: TNM Classification of Malignant Tumours. New York: Wiley 2002
28. Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
29. Ito F, Cho CS, Rikkers LF et al. Hilar cholangiocarcinoma: current management. Ann Surg 2009; 250: 210-218.
30. Chaudhry IH, Campbell F. An audit of pathology lymph node dissection techniques in pylorus preserving Kausch-Whipple pancreatoduodenectomy specimens. J Clin Pathol 2001; 54: 758-761.
31. Lagarde SM, Reitsma JB, de Castro SM et al. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastrooesophageal junction. Br J Surg 2007; 94: 1361-1368.
32. Anderson C, Kim R. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Cancer Treat Rev 2009; 35: 322-327.
33. Kloek JJ, Ten Kate FJ, Busch OR et al. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008; 10: 190-195.